Amoy Diagnostics (300685.SZ) has accumulated repurchased 1.07% of its shares amounting to 78.4975 million yuan.
Eden Bio announced that the company will trade by the method of centralized bidding trading until September 19, 2024.
Amoy Diagnostics (300685.SZ) announced that as of September 19, 2024, the company has repurchased 4.2527 million shares through centralized bidding transactions, accounting for 1.07% of the company's total share capital. The total amount paid was 78.4975 million yuan (excluding transaction fees).
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
